Tango Therapeutics Statistics
Total Valuation
TNGX has a market cap or net worth of $828.13 million. The enterprise value is $529.31 million.
| Market Cap | 828.13M |
| Enterprise Value | 529.31M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, before market open.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TNGX has 106.72 million shares outstanding. The number of shares has increased by 7.69% in one year.
| Shares Outstanding | 106.72M |
| Shares Change (YoY) | +7.69% |
| Shares Change (QoQ) | +7.68% |
| Owned by Insiders (%) | 13.51% |
| Owned by Institutions (%) | 88.54% |
| Float | 46.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 22.67 |
| Forward PS | 29.35 |
| PB Ratio | 3.27 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 14.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.54, with a Debt / Equity ratio of 0.15.
| Current Ratio | 7.54 |
| Quick Ratio | n/a |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -42.00% and return on invested capital (ROIC) is -39.10%.
| Return on Equity (ROE) | -42.00% |
| Return on Assets (ROA) | -25.20% |
| Return on Capital (ROIC) | -39.10% |
| Revenue Per Employee | $260,907 |
| Profits Per Employee | -$726,743 |
| Employee Count | 140 |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TNGX has paid $134,000 in taxes.
| Income Tax | 134,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +119.21% in the last 52 weeks. The beta is 0.84, so TNGX's price volatility has been lower than the market average.
| Beta (1Y) | 0.84 |
| 52-Week Price Change | +119.21% |
| 50-Day Moving Average | 9.23 |
| 200-Day Moving Average | 8.52 |
| Relative Strength Index (RSI) | 44.58 |
| Average Volume (30 Days) | 606,291 |
Short Selling Information
The latest short interest is 10.19 million, so 9.55% of the outstanding shares have been sold short.
| Short Interest | 10.19M |
| Short Previous Month | 8.88M |
| Short % of Shares Out | 9.55% |
| Short % of Float | 22.03% |
| Short Ratio (days to cover) | 13.95 |
Income Statement
In the last 12 months, TNGX had revenue of $36.53 million and -$101.74 million in losses. Loss per share was -$1.08.
| Revenue | 36.53M |
| Gross Profit | 36.53M |
| Operating Income | -114.17M |
| Pretax Income | -101.61M |
| Net Income | -101.74M |
| EBITDA | -95.59M |
| EBIT | -101.61M |
| Loss Per Share | -$1.08 |
Balance Sheet
The company has $337.74 million in cash and $38.92 million in debt, giving a net cash position of $298.82 million or $2.80 per share.
| Cash & Cash Equivalents | 337.74M |
| Total Debt | 38.92M |
| Net Cash | 298.82M |
| Net Cash Per Share | $2.80 |
| Equity / Book Value | 253.11M |
| Book Value Per Share | 2.37 |
| Working Capital | 300.60M |
Cash Flow
In the last 12 months, operating cash flow was -$117.98 million and capital expenditures -$1.53 million, giving a free cash flow of -$119.51 million.
| Operating Cash Flow | -117.98M |
| Capital Expenditures | -1.53M |
| Free Cash Flow | -119.51M |
| FCF Per Share | -$1.26 |
Margins
Gross margin is 100.00%, with operating and profit margins of -312.57% and -278.54%.
| Gross Margin | 100.00% |
| Operating Margin | -312.57% |
| Pretax Margin | -278.18% |
| Profit Margin | -278.54% |
| EBITDA Margin | -261.69% |
| EBIT Margin | -278.18% |
| FCF Margin | -327.18% |
Dividends & Yields
TNGX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.69% |
| Shareholder Yield | -7.69% |
| Earnings Yield | -12.29% |
| FCF Yield | -14.43% |
Analyst Forecast
The average price target for TNGX is $17.25, which is 122.29% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.25 |
| Price Target Difference | 122.29% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 74.66% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TNGX has an Altman Z-Score of 2.19 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.19 |
| Piotroski F-Score | 3 |